Subsequent Indications in Oncology Drugs: Pathways, Timelines, and the Inflation Reduction Act
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1